Oculir Inc., located in San Diego, CA, is developing a non-invasive meter that measures glucose from the white of the eye (the conjunctiva). Per the company, no contact with the eye is required; as the meter just needs to be pointed at the eye and click. The commercial version of the Oculir glucose sensor will be the size of a cell phone.Oculir was shut down in March 2008 after the U.S. Patent and Trademark Office (USPTO) held that all claims in Oculirs Patent No. 6,958,039 were invalid as not patentable based on prior art from a patent disclosure by Yale researcher, Dr. Marc Abreu. This final rejection by the USPTO forced Oculir to shutter the company and return an undisclosed sum to investors,
Missing: Oculir's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Oculir's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Oculir Frequently Asked Questions (FAQ)
When was Oculir founded?
Oculir was founded in 2003.
Where is Oculir's headquarters?
Oculir's headquarters is located at 11975 El Camino Real, San Diego.
What is Oculir's latest funding round?
Oculir's latest funding round is Dead.
How much did Oculir raise?
Oculir raised a total of $7.3M.
Who are the investors of Oculir?
Investors of Oculir include CHL Medical Partners, Three Arch Partners, Shepherd Ventures, Windamere Venture Partners, Canaan Partners and 3 more.
Who are Oculir's competitors?
Competitors of Oculir include btt, NeuroSky, Oraya Therapeutics, EyeTechCare, Biorasis and 11 more.
Compare Oculir to Competitors
eSight creates electronic glasses that restore or enhance sight for individuals living with vision loss. Worn comfortably like a normal pair of glasses or with prescription lenses built-in, they allow a person with low vision to see in virtually the same manner as someone who is fully-sighted can. The company's SPEX enhances vision for precision tasks, allowing users to pan and zoom the real world or streamed images, and brings critical information to the point of task without overwriting or obstructing natural vision for full situational awareness and mobility.
Kjaya is a company that received a SBIR Phase I grant for a project entitled: Semi-Autonomous Adaptive Neural and Genetic Segmentation of Medical Images. Their Phase I project will implement a physician-assisted, real-time adaptive system for the segmentation of anatomical structures in 3D medical image data. Medical image segmentation seeks to change the representation of an anatomical structure, making it more easily analyzed. Because of the extreme variability of these structures in biological systems, current idiosyncratic manual methods currently in use are tedious, time consuming, and error prone. Image segmentation cannot in general be programmatically solved. The proposed system is a Neural Network (NN) based adaptation of the individual data using parallel Graphics Processing Units (GPUs) and coupled with a Genetic Algorithm (GA) based adaptation across GPU cores. The system will build a diagnostically useful segmentation of the anatomical feature within seconds from an area of interest outlined by a physician using a Computed Tomography (CT) or Magnetic Resonance Imaging (MRI) scan. Fast growth in medical imaging overwhelms available diagnosticians. An intuitive and inexpensive system to quickly and accurately deliver diagnostic relevant segmentation of medical images offers tremendous commercial value. Currently, each scan requires approximately 50 minutes of manual preparation. The diagnosis and treatment of an estimated 20 percent of diseases benefit from medical imaging. Newer scanning technologies have increased in resolution, but such techniques have not made segmenting easier or faster. The proposed method will enable more diagnostics to be done with the quality controlled directly by physicians.
River Diagnostics is dedicated to the development of products for the healthcare and medical research marketplace based on the vast potential of non-invasive/non-destructive Raman spectroscopy. Today researchers in personal care, and dermatological research are using River Diagnostics' instruments to understand the metabolic processes in the skin, and other fundamental research questions.
Lumineyes uses a laser to heat the pigment layer of their eye to allow people with brown eyes to turn them permanently green or blue.
BioResonator aims to measure eye pressure with the resonance frequency.
AnaeMedia is a socio-technological initiative. The company have developed a prick-less anaemia scanner that can measure HB levels and help diagnose anaemia by referring to an accompanying simple chart.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.